arrow
K

Kei Nakagawa

tohoku medical & pharmaceutical university
H指数:29
被引数:3,167

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction

更正:HER2/ERBB2扩增及与胰胆管合流异常相关的胆囊癌的分子机制

2025-11-260
OAAI
Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction

胆囊癌中HER2/ERBB2扩增与致癌作用的分子机制研究

2025-10-040
OA
Outcomes of FOLFIRINOX versus Gemcitabine plus nab-Paclitaxel in Patients with Early Recurrent Pancreatic Cancer after Adjuvant S-1 Treatment: A propensity Score-matched Analysis

FOLFIRINOX与吉西他滨联合nab-紫杉醇在S-1辅助治疗后早期复发性胰腺癌患者中的疗效比较:一项倾向性评分匹配分析

2025-08-300
PRE
Deep learning predicts the 1-year prognosis of pancreatic cancer patients using positive peritoneal washing cytology
2024-08-020
OAAI
GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthetic pathway in pancreatic cancer

GFPT2表达由吉西他滨诱导,并通过激活胰腺癌中的己糖胺生物合成途径增强侵袭

2024-06-180
OAAI
Clonal analysis of metachronous double biliary tract cancers

异时性双胆道癌的克隆分析

2024-03-141
OA